NCT04982796View on ClinicalTrials.gov

Psilocybin-Enhanced Psychotherapy for Methamphetamine Use Disorder

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

July 7, 2022

Primary Completion Date

December 31, 2025

Study Completion Date

April 30, 2026

Conditions
Amphetamine-Related Disorders
Interventions
DRUG

Psilocybin

See description of psilocybin-enhanced psychotherapy arm.

BEHAVIORAL

Treatment-as-usual

See description of treatment-as-usual arm.

Trial Locations (1)

98661

RECRUITING

Portland VA Health Care System, Vancouver

All Listed Sponsors
collaborator

Steven & Alexandra Cohen Foundation

OTHER

lead

Portland VA Research Foundation, Inc

OTHER